Search
Nuvectis Pharma Inc
NVCTAdd to Watchlist
21.520USD
0.0000.00%
Close 07-31 16:00（ET）Quotes delayed by 15 min
570.83MMarket Cap
LossP/E TTM
NVCT Financials
See Nuvectis Pharma Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Nuvectis Pharma Inc Earnings Date
Latest Release
May 5, 2026
EPS / Forecast
-0.26/-0.31
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-1.32
-19.21%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Nuvectis Pharma Inc?
According to Nuvectis Pharma Inc's FY2025 earnings report, its current assets were 31.71M, with a year-on-year change of 70.41.
What are the total assets of Nuvectis Pharma Inc?
According to Nuvectis Pharma Inc's FY2025 earnings report, its total assets of Nuvectis Pharma Inc were 31.71M, with a year-on-year change of 70.41.
What are the total liabilities of Nuvectis Pharma Inc?
According to Nuvectis Pharma Inc's FY2025 earnings report, its total liabilities of Nuvectis Pharma Inc were 13.30M, with a year-on-year change of 49.49.
What is the total equity of Nuvectis Pharma Inc?
According to Nuvectis Pharma Inc's FY2025 earnings report, its total equity of Nuvectis Pharma Inc was 18.41M, with a year-on-year change of 89.57.
What is the net operating income of Nuvectis Pharma Inc?
According to Nuvectis Pharma Inc's FY2025 earnings report, its net operating income of Nuvectis Pharma Inc was -27.57M, with a year-on-year change of -38.93.
What is the net financing of Nuvectis Pharma Inc?
According to Nuvectis Pharma Inc's FY2025 earnings report, its net financing of Nuvectis Pharma Inc was 29.11M, with a year-on-year change of 149.79.
What is the Earnings Per Share (EPS) of Nuvectis Pharma Inc?
According to Nuvectis Pharma Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.32, with a year-on-year change of -19.21.
What is the net income of Nuvectis Pharma Inc?
According to Nuvectis Pharma Inc's FY2025 earnings report, its net income was -28.87M, with a year-on-year change of -51.95.
What is the Return on Equity (ROE) of Nuvectis Pharma Inc?
According to Nuvectis Pharma Inc's FY2025 earnings report, its Return on Equity (ROE) was -205.30, with a year-on-year change of -18.39.
What is the Return on Assets (ROA) of Nuvectis Pharma Inc?
According to Nuvectis Pharma Inc's FY2025 earnings report, its Return on Assets (ROA) was -105.10, with a year-on-year change of -4.53.
What is the operating profit of Nuvectis Pharma Inc?
According to Nuvectis Pharma Inc's FY2025 earnings report, its operating profit was -27.57M, with a year-on-year change of -38.93.